<DOC>
	<DOCNO>NCT00168376</DOCNO>
	<brief_summary>The study involve 3-week ( 15 session ) randomize double-blind clinical trial two repetitive transcranial magnetic stimulation ( rTMS ) condition patient treatment resistant depression . rTMS site selection localize structural MRI scan . The patient randomize one two condition 1. rTMS target border Brodmann area 46 Brodmann area 9 , 2. rTMS target premotor cortex ( condition act non-dorsolateral prefrontal cortex target control ) .</brief_summary>
	<brief_title>A Randomised Double-Blind Trial Targeted Repetitive Transcranial Magnetic Stimulation Major Depressive Disorder</brief_title>
	<detailed_description>The outcome measure use MADRS ( Montgomery-Asberg Depression Rating Scale ) . This administered baseline fortnightly basis . At study end response criterion define 50 % reduction total MADRS score remission define MADRS score less equal 10 . Other outcome measure administer fortnightly : BPRS ( Brief Psychiatric Rating Scale ) , CORE ( measure melancholic symptom ) , BDI ( Beck Depression Inventory ) , CGI ( Clinical Global Impression Scale ) , GAF ( Global Assessment Functioning Scale ) . A cognitive battery also administer . Inclusion Criteria : - Moderate severe depressive symptom indicate MADRS &gt; 20 - Failure respond minimum two antidepressant medication - No increase initiation new antidepressant therapy four week prior enter trial Exclusion Criteria - Have unstable medical condition , neurological disorder history seizure disorder currently pregnant lactate - Previous brain injury surgery , metal clip , plat metal item head , cardiac pacemaker - In opinion investigator , sufficient suicide risk require immediate electroconvulsive therapy - Have current DSMIV diagnosis substance abuse dependence disorder , diagnosis personality disorder another axis 1 disorder</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Moderate severe depressive symptom indicate MADRS &gt; 20 Failure respond minimum two antidepressant medication No increase initiation new antidepressant therapy four week prior enter trial Have unstable medical condition , neurological disorder history seizure disorder currently pregnant lactate Previous brain injury surgery , metal clip , plat metal item head , cardiac pacemaker In opinion investigator , sufficient suicide risk require immediate electroconvulsive therapy Have current DSMIV diagnosis substance abuse dependence disorder , diagnosis personality disorder another axis 1 disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Transcranial Magnetic Stimulation</keyword>
	<keyword>Depression</keyword>
</DOC>